Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver disease

被引:16
|
作者
Cai, Changzhou [1 ]
Song, Xin [1 ]
Yu, Chaohui [1 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Expression; bioinformatics; hepatocellular carcinoma; non-alcoholic fatty liver disease; CEP192; STEATOHEPATITIS; EPIDEMIOLOGY; BIOMARKERS; MICRORNAS; PATHWAY; CYCLE;
D O I
10.3233/CBM-190169
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Hepatocellular carcinoma (HCC) is the leading cause of mortality worldwide. In recent years, the incidence of HCC induced by NAFLD is growing rapidly. OBJECTIVE: To screen for new pathogenic genes and related pathways both in NAFLD and HCC, and to explore the pathogenesis of progression from NAFLD to HCC. METHODS: Gene expression microarrays (GSE74656, GSE62232) were used for identifying differentially expressed genes (DEGs). Functional enrichment and pathway enrichment analyses indicated that these DEGs were related to cell cycle and extracellular exosome, which were closely related to NAFLD and HCC development. We then used the Search Tool for the Retrieval of Interacting Genes (STRING) to establish the protein-protein interaction (PPI) network and visualized them in Cytoscape. And the overall survival (OS) analysis and gene expression validation in TCGA of hub genes was performed. RESULTS: Seven hub genes, including CDK1, HSP90AA1, MAD2L1, PRKCD, ITGB3BP, CEP192, and RHOB were identified. Finally, we verified the expression level of ITGB3BP and CEP192 by quantitative real-time PCR in vitro. CONCLUSIONS: The present study implied possible DEGs, especially the new gene CEP192, in the progression of NAFLD developing to HCC. Further rigorous experiments are required to verify the above results.
引用
收藏
页码:69 / 78
页数:10
相关论文
共 50 条
  • [21] Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover
    Simon, Jorge
    Ouro, Alberto
    Ala-Ibanibo, Lolia
    Presa, Natalia
    Cardoso Delgado, Teresa
    Luz Martinez-Chantar, Maria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (01)
  • [22] Management of non-alcoholic fatty liver disease-associated hepatocellular carcinoma
    Xu, Peijun
    Liu, Maoyun
    Liu, Miao
    Shen, Ai
    BIOSCIENCE TRENDS, 2024,
  • [23] Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges
    Teng, Yu-Xian
    Xie, Si
    Guo, Ping-Ping
    Deng, Zhu-Jian
    Zhang, Zi-Yi
    Gao, Wei
    Zhang, Wan-Guang
    Zhong, Jian-Hong
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (05) : 955 - 964
  • [24] Systemic treatment of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease
    Rzeniewicz, Karolina
    Sharma, Rohini
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2024, 15 (11):
  • [25] Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern
    Dhamija, Ekta
    Paul, Shashi Bala
    Kedia, Saurabh
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2019, 149 (01) : 9 - 17
  • [26] Ultrasonography in surveillance for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
    Hydes, Theresa J.
    Cuthbertson, Daniel J.
    Palmer, Daniel H.
    Elshaarawy, Omar
    Johnson, Philip J.
    Fernando, Rashika
    Cross, Timothy J.
    HEPATOMA RESEARCH, 2023, 9
  • [27] Epidemiology of non-alcoholic fatty liver disease and risk of hepatocellular carcinoma progression
    Thandra, Krishna Chaitanya
    Barsouk, Adam
    Saginala, Kalyan
    Aluru, John Sukumar
    Rawla, Prashanth
    Barsouk, Alexander
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 6 (04) : 289 - 294
  • [28] PREDICTORS OF THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
    Lee, Jae Seung
    Sinn, Dong Hyun
    Lee, Hye Won
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Lee, Jung Il
    Kim, Seung Up
    HEPATOLOGY, 2021, 74 : 978A - 979A
  • [29] Risk Stratification for Hepatocellular Carcinoma in Patients with Non-alcoholic Fatty Liver Disease
    Truong E.
    Han C.
    Muthiah M.
    Noureddin M.
    Current Hepatology Reports, 2023, 22 (1) : 1 - 8
  • [30] Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention
    Baffy, Gyorgy
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2013, 1 (02) : 131 - 137